Literature DB >> 20551948

Stem cell therapies for spinal cord injury.

Vibhu Sahni1, John A Kessler.   

Abstract

Stem cell therapy is a potential treatment for spinal cord injury (SCI), and a variety of different stem cell types have been evaluated in animal models and humans with SCI. No consensus exists regarding the type of stem cell, if any, that will prove to be effective therapeutically. Most data suggest that no single therapy will be sufficient to overcome all the biological complications caused by SCI. Rationales for therapeutic use of stem cells for SCI include replacement of damaged neurons and glial cells, secretion of trophic factors, regulation of gliosis and scar formation, prevention of cyst formation, and enhancement of axon elongation. Most therapeutic approaches that use stem cells involve implantation of these cells into the spinal cord. The attendant risks of stem cell therapy for SCI--including tumor formation, or abnormal circuit formation leading to dysfunction--must be weighed against the potential benefits of this approach. This Review will examine the biological effects of SCI, the opportunities for stem cell treatment, and the types of stem cells that might be used therapeutically. The limited information available on the possible benefits of stem cell therapy to humans will also be discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20551948      PMCID: PMC3755897          DOI: 10.1038/nrneurol.2010.73

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  126 in total

1.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.

Authors:  C P Hofstetter; E J Schwarz; D Hess; J Widenfalk; A El Manira; Darwin J Prockop; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Repairing the injured spinal cord.

Authors:  Martin E Schwab
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

Review 3.  Stem cell biology of the central nervous system.

Authors:  Hideyuki Okano
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

4.  Directed differentiation of embryonic stem cells into motor neurons.

Authors:  Hynek Wichterle; Ivo Lieberam; Jeffery A Porter; Thomas M Jessell
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

5.  Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord.

Authors:  A C Lepore; I Fischer
Journal:  Exp Neurol       Date:  2005-07       Impact factor: 5.330

Review 6.  Epidemiology, demographics, and pathophysiology of acute spinal cord injury.

Authors:  L H Sekhon; M G Fehlings
Journal:  Spine (Phila Pa 1976)       Date:  2001-12-15       Impact factor: 3.468

7.  Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury.

Authors:  Hans S Keirstead; Gabriel Nistor; Giovanna Bernal; Minodora Totoiu; Frank Cloutier; Kelly Sharp; Oswald Steward
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

8.  Chondroitinase ABC promotes functional recovery after spinal cord injury.

Authors:  Elizabeth J Bradbury; Lawrence D F Moon; Reena J Popat; Von R King; Gavin S Bennett; Preena N Patel; James W Fawcett; Stephen B McMahon
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

9.  Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

Authors:  Rakhi Pal; Neelam K Venkataramana; Abhilash Bansal; Sudheer Balaraju; Majahar Jan; Ravi Chandra; Ashish Dixit; Amit Rauthan; Uday Murgod; Satish Totey
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

10.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

View more
  78 in total

Review 1.  Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening.

Authors:  Sareh Pandamooz; Mohammad Nabiuni; Jaleel Miyan; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons.

Authors:  Lei Zhang; Jiu-Chao Yin; Hana Yeh; Ning-Xin Ma; Grace Lee; Xiangyun Amy Chen; Yanming Wang; Li Lin; Li Chen; Peng Jin; Gang-Yi Wu; Gong Chen
Journal:  Cell Stem Cell       Date:  2015-10-17       Impact factor: 24.633

3.  Alternating current electric fields of varying frequencies: effects on proliferation and differentiation of porcine neural progenitor cells.

Authors:  Ji-Hey Lim; Seth D McCullen; Jorge A Piedrahita; Elizabeth G Loboa; Natasha J Olby
Journal:  Cell Reprogram       Date:  2013-08-20       Impact factor: 1.987

4.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

5.  Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.

Authors:  J Illes; J C Reimer; B K Kwon
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

Review 6.  Emerging therapies for acute traumatic spinal cord injury.

Authors:  Jefferson R Wilson; Nicole Forgione; Michael G Fehlings
Journal:  CMAJ       Date:  2012-12-10       Impact factor: 8.262

Review 7.  Hydrogels in spinal cord injury repair strategies.

Authors:  Giuseppe Perale; Filippo Rossi; Erik Sundstrom; Sara Bacchiega; Maurizio Masi; Gianluigi Forloni; Pietro Veglianese
Journal:  ACS Chem Neurosci       Date:  2011-05-04       Impact factor: 4.418

8.  Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes.

Authors:  Abel Torres-Espín; Elena Redondo-Castro; Joaquim Hernandez; Xavier Navarro
Journal:  J Neurotrauma       Date:  2015-01-22       Impact factor: 5.269

9.  Valproic acid preserves motoneurons following contusion in organotypic spinal cord slice culture.

Authors:  Sareh Pandamooz; Mohammad Saied Salehi; Mohammad Nabiuni; Leila Dargahi
Journal:  J Spinal Cord Med       Date:  2016-08-31       Impact factor: 1.985

10.  Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study.

Authors:  H S Chhabra; K Sarda; M Arora; R Sharawat; V Singh; A Nanda; G M Sangodimath; V Tandon
Journal:  Spinal Cord       Date:  2015-08-18       Impact factor: 2.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.